Novel acylated phospholipid drugs

Details Novel acylated phospholipid drugs Novel acylated phospholipid drugs

C - Chemistry, Metallurgy

07

F

C07F 9/09 (2006.01) A61K 31/66 (2006.01) C07F 9/10 (2006.01) C07F 9/117 (2006.01)

Patent

CA 2133444

2133444 9321191 PCTABS00027 The invention relates to a compound having formula (A) or pharmaceutically acceptable salts thereof, wherein one of R1 and R2 is a heteroatom fatty acid acyl group having 13-14 carbon atoms in the principal chain and up to a total of 18 carbon atoms, while the other is hydrogen, a heteroatom of fatty acid acyl group containing 13-14 carbon atoms in the principal chain and up to a total of 18 carbon atoms or an acyl group of a fatty acid containing 4-26 carbon atoms in the principal chain and up to a total of 30 carbon atoms and R is a naturally occurring polar group characteristic of a glycerolphospholipid isolated from endogenous sources. This invention also relates to the use of the compounds of the present invention for inhibiting retrovirus infections and for the treatment of AIDS or AIDS related diseases.

Affiliated with

Also associated with

Rating

Novel acylated phospholipid drugs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel acylated phospholipid drugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel acylated phospholipid drugs will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1714021